The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment

RecruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

March 9, 2015

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Prostate CancerProstate BiopsyGenetic CounsellingGenetic Markers
Interventions
PROCEDURE

Prostate MRI and Biopsy

All men will be offered a MRI and prostate biopsy and they can either opt to undergo these procedures at baseline irrespective of PSA level at baseline or they can undergo PSA-only screening until clinically indicated based on an age-defined PSA threshold, at which point, they will undergo prostate MRI and biopsy once their PSA reaches the threshold.

Trial Locations (1)

SM2 5PT

RECRUITING

Institute of Cancer Research and Royal Marsden Hospital, Sutton

All Listed Sponsors
collaborator

Royal Marsden NHS Foundation Trust

OTHER

collaborator

University of Cambridge

OTHER

collaborator

University of Oxford

OTHER

collaborator

Queen Mary University of London

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER